ArticleNeuroImage. Clinical2025
Distinct cortical morphometric inverse divergence changes in Parkinson's disease correlate with transcriptional expression patterns.
Article in NeuroImage. Clinical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Morphometric Inverse Divergence Networks Combined with HYDRA Identify Parkinson's Disease Subtypes with Distinct Transcriptomic and Serum Biomarker Profiles.International journal of molecular sciences · 2026Article
- Associations between altered morphometric inverse divergence networks, choroid plexus volume, and perivascular space network in patients with Parkinson disease: a cross-sectional study.Quantitative imaging in medicine and surgery · 2026Article
- The genetic architecture of cortical similarity networks.Nature communications · 2026Article
- Investigation of cerebral cortical morphological similarity and network topological abnormalities in hepatic encephalopathy utilizing a morphometric inverse divergence network framework.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growing evidence shows that parkinson's disease (PD) is a heterogeneous neurodegenerative disorder associated with region-specific changes in brain anatomy. However, the genetic mechanisms underlining these abnormalities are unclear. We aim to investigate PD neuroanatomical subtypes and uncover the specific brain-wide gene expression associated with morphometric abnormalities in each PD subtype. The morphometric inverse divergence (MIND) algorithm was used to quantify the morphological similarity based on multiple MRI features in 127 patients with PD and 101 healthy controls (HC). Then, heterogeneity through discriminant analysis (HYDRA) was employed to investigate the PD subtypes based on the MIND strength. Intergroup comparisons were conducted to assess MIND strength and clinical behavioral differences among PD subtypes and HC. Finally, we explored the associations between MIND network changes and gene expression in each PD subtype through partial least squares (PLS) regression, functional enrichment of PLS-weighted genes and transcriptional signature assessment of cell types. We identified two distinct subtypes of PD-related MIND changes, indicating that MIND decreased mainly in the frontal and cingulate cortices in subtype 1, and increased mainly in the occipital cortex and postcentral gyrus in subtype 2 (Bonferroni correction, p < 0.05). Both PD subtypes exhibited impaired cognitive function compared to HC, with subtype 2 showing lower Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) and Hoehn and Yahr (H&Y) scores than subtype 1. Moreover, genetic commonalities analysis were identified 5 shared negative genes in the PD subtypes. Subtype 1 PLS1 genes were functionally enriched in biological processes related to synaptic function, neurodevelopment and degeneration. In addition, subtype 2 PLS1 genes showed additional involvement of metabolic pathways alongside synaptic function. Moreover, we identified MIND-related genes involved in inhibitory and excitatory neurons in subtype 1. In subtype 2, MIND-related genes were involved in astrocytes besides excitatory and inhibitory neurons. Our findings suggest two distinct neuroanatomical subtypes in PD, deepening the understanding of the heterogeneity of PD by bridging the gap between the transcriptome and neuroimaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.